Related Experiment Video
Updated: Jul 9, 2026
08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
[Parenchymatous-stromal factors in hemoblastoses]
Arkhiv Patologii
|December 14, 2007
Summary
This study explores how new blood vessel formation and extracellular matrix influence leukemia and lymphoproliferative diseases. Understanding these factors is key to developing targeted therapies for blood cancers.
Area of Science:
- Hematology
- Oncology
- Cell Biology
Context:
- Leukemias and lymphoproliferative diseases involve complex cellular interactions.
- Neoangiogenesis and extracellular matrix (ECM) play critical roles in disease pathogenesis.
- Hematopoiesis and endothelial cells share a common progenitor, highlighting developmental links.
Purpose:
- To review the literature on the role of neoangiogenesis and ECM in leukemia and lymphoproliferative diseases.
- To elucidate the involvement of angiogenic and fibroblast growth factors in chronic leukemia.
- To examine how lymphoid cell phenotype influences cellular and extracellular factor interactions.
Summary:
- The literature suggests neoangiogenesis and ECM factors are integral to the pathogenesis of acute and chronic leukemias and lymphoproliferative disorders.
- Angiogenic and fibroblast growth factors are implicated in the development of chronic leukemia.
- Lymphoid cell phenotype dictates the specific cellular and extracellular factors involved in disease progression.
Impact:
- Provides a comprehensive overview of key factors in leukemia and lymphoproliferative disease pathogenesis.
- Highlights the shared progenitor of hematopoietic and endothelial cells, suggesting therapeutic targets.
- Emphasizes the influence of lymphoid cell phenotype on disease mechanisms, aiding in personalized medicine approaches.
Related Concept Videos
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
01:34Production of Formed Elements
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
01:24Factors Affecting Erythropoiesis
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...